HEADER LIPID BINDING PROTEIN 17-OCT-23 8UM5 TITLE X-RAY STRUCTURE OF HUMAN SHIP1 PTASE-C2 DOMAINS COVALENTLY BOUND TO TITLE 2 TREAT-AD (TAD) COMPOUND TAD-58547 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHATIDYLINOSITOL 3,4,5-TRISPHOSPHATE 5-PHOSPHATASE 1; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: INPP5D; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SHIP1, INPP5D, ALZHEIMER'S DISASE, TREAT-AD, INHIBITOR, LIPID BINDING KEYWDS 2 PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.D.MESECAR,A.K.HAMDANI REVDAT 1 23-OCT-24 8UM5 0 JRNL AUTH A.K.HAMDANI,A.D.MESECAR JRNL TITL X-RAY STRUCTURE OF HUMAN SHIP1 PTASE-C2 DOMAINS COVALENTLY JRNL TITL 2 BOUND TO TREAT-AD (TAD) COMPOUND TAD-58547 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.86 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.86 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.87 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.370 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 36834 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.160 REMARK 3 R VALUE (WORKING SET) : 0.158 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1843 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 24.8700 - 4.3700 0.99 2769 146 0.1367 0.1835 REMARK 3 2 4.3700 - 3.4700 0.98 2717 144 0.1336 0.1705 REMARK 3 3 3.4700 - 3.0300 1.00 2729 143 0.1551 0.2201 REMARK 3 4 3.0300 - 2.7600 1.00 2735 145 0.1698 0.2251 REMARK 3 5 2.7600 - 2.5600 1.00 2725 143 0.1837 0.2171 REMARK 3 6 2.5600 - 2.4100 1.00 2742 144 0.1739 0.2457 REMARK 3 7 2.4100 - 2.2900 0.99 2725 144 0.1675 0.1951 REMARK 3 8 2.2900 - 2.1900 0.99 2707 142 0.1722 0.2466 REMARK 3 9 2.1900 - 2.1000 0.99 2677 141 0.1762 0.2218 REMARK 3 10 2.1000 - 2.0300 0.99 2696 142 0.1791 0.2413 REMARK 3 11 2.0300 - 1.9700 0.99 2698 143 0.1881 0.2614 REMARK 3 12 1.9700 - 1.9100 0.98 2685 141 0.1957 0.2497 REMARK 3 13 1.9100 - 1.8600 0.88 2386 125 0.2249 0.2805 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.212 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 20.495 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 28.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.77 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 3902 REMARK 3 ANGLE : 0.970 5303 REMARK 3 CHIRALITY : 0.063 576 REMARK 3 PLANARITY : 0.008 684 REMARK 3 DIHEDRAL : 6.515 515 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 395 THROUGH 504 ) REMARK 3 ORIGIN FOR THE GROUP (A): -12.5512 -20.5059 20.0483 REMARK 3 T TENSOR REMARK 3 T11: 0.3071 T22: 0.4013 REMARK 3 T33: 0.3764 T12: -0.0973 REMARK 3 T13: 0.1336 T23: 0.0121 REMARK 3 L TENSOR REMARK 3 L11: 1.6531 L22: 1.4551 REMARK 3 L33: 2.2597 L12: -0.0398 REMARK 3 L13: 0.0992 L23: 0.3257 REMARK 3 S TENSOR REMARK 3 S11: 0.0113 S12: -0.3836 S13: -0.2446 REMARK 3 S21: 0.4572 S22: -0.1397 S23: 0.5062 REMARK 3 S31: 0.4265 S32: -0.5994 S33: 0.0575 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 505 THROUGH 617 ) REMARK 3 ORIGIN FOR THE GROUP (A): -0.5240 -10.8233 7.8398 REMARK 3 T TENSOR REMARK 3 T11: 0.1173 T22: 0.1292 REMARK 3 T33: 0.1509 T12: -0.0033 REMARK 3 T13: 0.0144 T23: 0.0291 REMARK 3 L TENSOR REMARK 3 L11: 1.7488 L22: 2.8744 REMARK 3 L33: 3.3633 L12: 0.0290 REMARK 3 L13: 0.4470 L23: 1.5275 REMARK 3 S TENSOR REMARK 3 S11: -0.0980 S12: 0.0385 S13: 0.0785 REMARK 3 S21: -0.1598 S22: -0.0345 S23: 0.1265 REMARK 3 S31: -0.2187 S32: -0.1847 S33: 0.0994 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN 'A' AND (RESID 618 THROUGH 856 ) REMARK 3 ORIGIN FOR THE GROUP (A): 9.7604 -7.7476 17.9106 REMARK 3 T TENSOR REMARK 3 T11: 0.1679 T22: 0.1783 REMARK 3 T33: 0.1986 T12: 0.0388 REMARK 3 T13: -0.0102 T23: 0.0237 REMARK 3 L TENSOR REMARK 3 L11: 1.9204 L22: 2.1501 REMARK 3 L33: 2.6845 L12: 0.1186 REMARK 3 L13: 1.0865 L23: 0.5093 REMARK 3 S TENSOR REMARK 3 S11: -0.1660 S12: -0.0696 S13: 0.1850 REMARK 3 S21: 0.2041 S22: 0.0309 S23: -0.2331 REMARK 3 S31: -0.1892 S32: 0.1690 S33: 0.0986 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8UM5 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000278384. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-OCT-21 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-F REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97872 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-300 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 36968 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.860 REMARK 200 RESOLUTION RANGE LOW (A) : 24.870 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.06535 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9900 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.86 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.93 REMARK 200 COMPLETENESS FOR SHELL (%) : 90.8 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.61350 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.490 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 17-22% PEG 2000 MME, 7-10% PEG 3000 REMARK 280 AND 0.1M HEPES PH 7.0. PROTEIN CRYSTALLIZATION WAS PERFORMED IN REMARK 280 24-WELL SITTING DROP PLATES WITH A 1:1 RATIO OF PROTEIN TO REMARK 280 RESERVOIR SOLUTION (FINAL VOLUME OF 3 UL). CRYSTALS WERE ALLOWED REMARK 280 TO GROW FOR AT LEAST 1 WEEK AT ROOM TEMPERATURE. CRYSTALS AT REMARK 280 SIZES APPROPRIATE FOR X-RAY DATA COLLECTION WERE THEN REMARK 280 CRYOPROTECTED WITH 2.5 UL OF CRYOSOLUTION (90% RESERVOIR REMARK 280 SOLUTION + 10% PEG 400.) CRYSTALS WERE HARVESTED WITH NYLON REMARK 280 LOOPS AND FLASH-FROZEN IN LIQUID NITROGEN., VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.13300 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 394 REMARK 465 VAL A 716 REMARK 465 SER A 717 REMARK 465 LYS A 718 REMARK 465 ASN A 719 REMARK 465 GLY A 720 REMARK 465 PRO A 721 REMARK 465 GLY A 722 REMARK 465 THR A 723 REMARK 465 VAL A 724 REMARK 465 ASP A 725 REMARK 465 SER A 726 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 856 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 599 O HOH A 1001 1.97 REMARK 500 OE1 GLU A 599 O HOH A 1001 2.03 REMARK 500 OD1 ASP A 592 O HOH A 1002 2.03 REMARK 500 O HOH A 1289 O HOH A 1308 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 1290 O HOH A 1318 1455 1.97 REMARK 500 NZ LYS A 510 O SER A 771 1455 1.99 REMARK 500 O HOH A 1001 O HOH A 1266 2545 2.13 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 397 73.05 -116.74 REMARK 500 SER A 473 -19.06 81.54 REMARK 500 TRP A 485 -117.24 56.81 REMARK 500 ALA A 514 22.45 -144.08 REMARK 500 ASN A 515 -79.11 38.65 REMARK 500 ASN A 530 -123.42 55.34 REMARK 500 LEU A 648 -3.89 81.11 REMARK 500 THR A 741 156.71 -49.40 REMARK 500 SER A 753 144.27 -175.50 REMARK 500 ARG A 822 80.30 -65.60 REMARK 500 REMARK 500 REMARK: NULL DBREF 8UM5 A 396 856 UNP Q92835 SHIP1_HUMAN 397 857 SEQADV 8UM5 SER A 394 UNP Q92835 EXPRESSION TAG SEQADV 8UM5 MET A 395 UNP Q92835 EXPRESSION TAG SEQRES 1 A 463 SER MET GLU GLN PRO GLU PRO ASP MET ILE THR ILE PHE SEQRES 2 A 463 ILE GLY THR TRP ASN MET GLY ASN ALA PRO PRO PRO LYS SEQRES 3 A 463 LYS ILE THR SER TRP PHE LEU SER LYS GLY GLN GLY LYS SEQRES 4 A 463 THR ARG ASP ASP SER ALA ASP TYR ILE PRO HIS ASP ILE SEQRES 5 A 463 TYR VAL ILE GLY THR GLN GLU ASP PRO LEU SER GLU LYS SEQRES 6 A 463 GLU TRP LEU GLU ILE LEU LYS HIS SER LEU GLN GLU ILE SEQRES 7 A 463 THR SER VAL THR PHE LYS THR VAL ALA ILE HIS THR LEU SEQRES 8 A 463 TRP ASN ILE ARG ILE VAL VAL LEU ALA LYS PRO GLU HIS SEQRES 9 A 463 GLU ASN ARG ILE SER HIS ILE CYS THR ASP ASN VAL LYS SEQRES 10 A 463 THR GLY ILE ALA ASN THR LEU GLY ASN LYS GLY ALA VAL SEQRES 11 A 463 GLY VAL SER PHE MET PHE ASN GLY THR SER LEU GLY PHE SEQRES 12 A 463 VAL ASN SER HIS LEU THR SER GLY SER GLU LYS LYS LEU SEQRES 13 A 463 ARG ARG ASN GLN ASN TYR MET ASN ILE LEU ARG PHE LEU SEQRES 14 A 463 ALA LEU GLY ASP LYS LYS LEU SER PRO PHE ASN ILE THR SEQRES 15 A 463 HIS ARG PHE THR HIS LEU PHE TRP PHE GLY ASP LEU ASN SEQRES 16 A 463 TYR ARG VAL ASP LEU PRO THR TRP GLU ALA GLU THR ILE SEQRES 17 A 463 ILE GLN LYS ILE LYS GLN GLN GLN TYR ALA ASP LEU LEU SEQRES 18 A 463 SER HIS ASP GLN LEU LEU THR GLU ARG ARG GLU GLN LYS SEQRES 19 A 463 VAL PHE LEU HIS PHE GLU GLU GLU GLU ILE THR PHE ALA SEQRES 20 A 463 PRO THR TYR ARG PHE GLU ARG LEU THR ARG ASP LYS TYR SEQRES 21 A 463 ALA TYR THR LYS GLN LYS ALA THR GLY MET LYS TYR ASN SEQRES 22 A 463 LEU PRO SER TRP CYS ASP ARG VAL LEU TRP LYS SER TYR SEQRES 23 A 463 PRO LEU VAL HIS VAL VAL CYS GLN SER TYR GLY SER THR SEQRES 24 A 463 SER ASP ILE MET THR SER ASP HIS SER PRO VAL PHE ALA SEQRES 25 A 463 THR PHE GLU ALA GLY VAL THR SER GLN PHE VAL SER LYS SEQRES 26 A 463 ASN GLY PRO GLY THR VAL ASP SER GLN GLY GLN ILE GLU SEQRES 27 A 463 PHE LEU ARG CYS TYR ALA THR LEU LYS THR LYS SER GLN SEQRES 28 A 463 THR LYS PHE TYR LEU GLU PHE HIS SER SER CYS LEU GLU SEQRES 29 A 463 SER PHE VAL LYS SER GLN GLU GLY GLU ASN GLU GLU GLY SEQRES 30 A 463 SER GLU GLY GLU LEU VAL VAL LYS PHE GLY GLU THR LEU SEQRES 31 A 463 PRO LYS LEU LYS PRO ILE ILE SER ASP PRO GLU TYR LEU SEQRES 32 A 463 LEU ASP GLN HIS ILE LEU ILE SER ILE LYS SER SER ASP SEQRES 33 A 463 SER ASP GLU SER TYR GLY GLU GLY CYS ILE ALA LEU ARG SEQRES 34 A 463 LEU GLU ALA THR GLU THR GLN LEU PRO ILE TYR THR PRO SEQRES 35 A 463 LEU THR HIS HIS GLY GLU LEU THR GLY HIS PHE GLN GLY SEQRES 36 A 463 GLU ILE LYS LEU GLN THR SER GLN HET X3F A 901 19 HET DMS A 902 10 HET DMS A 903 10 HET DMS A 904 10 HETNAM X3F 5-(1,4-OXAZEPAN-4-YL)-6-PROPANOYLPYRIDINE-2- HETNAM 2 X3F CARBONITRILE HETNAM DMS DIMETHYL SULFOXIDE FORMUL 2 X3F C14 H17 N3 O2 FORMUL 3 DMS 3(C2 H6 O S) FORMUL 6 HOH *342(H2 O) HELIX 1 AA1 ILE A 421 SER A 427 1 7 HELIX 2 AA2 ASP A 435 ASP A 439 5 5 HELIX 3 AA3 SER A 456 SER A 473 1 18 HELIX 4 AA4 PRO A 495 GLU A 498 5 4 HELIX 5 AA5 LYS A 547 LEU A 562 1 16 HELIX 6 AA6 PRO A 594 TRP A 596 5 3 HELIX 7 AA7 GLU A 597 GLN A 607 1 11 HELIX 8 AA8 TYR A 610 SER A 615 1 6 HELIX 9 AA9 ASP A 617 GLU A 625 1 9 HELIX 10 AB1 GLN A 658 GLY A 662 5 5 HELIX 11 AB2 ASP A 792 LEU A 797 1 6 SHEET 1 AA1 7 GLN A 430 LYS A 432 0 SHEET 2 AA1 7 VAL A 684 SER A 691 -1 O SER A 691 N GLN A 430 SHEET 3 AA1 7 VAL A 703 GLY A 710 -1 O PHE A 704 N GLY A 690 SHEET 4 AA1 7 MET A 402 ASN A 411 -1 N ILE A 403 O ALA A 709 SHEET 5 AA1 7 ILE A 445 GLN A 451 1 O GLY A 449 N GLY A 408 SHEET 6 AA1 7 ILE A 487 ALA A 493 -1 O LEU A 492 N TYR A 446 SHEET 7 AA1 7 LYS A 477 LEU A 484 -1 N LEU A 484 O ILE A 487 SHEET 1 AA2 5 ILE A 501 LYS A 510 0 SHEET 2 AA2 5 GLY A 521 PHE A 529 -1 O GLY A 524 N ASP A 507 SHEET 3 AA2 5 THR A 532 HIS A 540 -1 O THR A 532 N PHE A 529 SHEET 4 AA2 5 HIS A 580 ASP A 586 1 O PHE A 584 N VAL A 537 SHEET 5 AA2 5 ASP A 672 SER A 678 -1 O LEU A 675 N TRP A 583 SHEET 1 AA3 5 GLU A 766 GLU A 769 0 SHEET 2 AA3 5 LEU A 775 GLY A 780 -1 O LYS A 778 N GLU A 766 SHEET 3 AA3 5 GLN A 729 LEU A 739 -1 N CYS A 735 O PHE A 779 SHEET 4 AA3 5 GLU A 841 GLN A 853 -1 O GLU A 849 N LEU A 733 SHEET 5 AA3 5 LEU A 830 HIS A 838 -1 N ILE A 832 O GLY A 848 SHEET 1 AA4 4 VAL A 760 LYS A 761 0 SHEET 2 AA4 4 PHE A 747 HIS A 752 -1 N PHE A 751 O VAL A 760 SHEET 3 AA4 4 HIS A 800 SER A 807 -1 O LYS A 806 N TYR A 748 SHEET 4 AA4 4 SER A 813 ALA A 820 -1 O TYR A 814 N ILE A 805 LINK SG CYS A 505 C01 X3F A 901 1555 1555 1.76 CISPEP 1 TYR A 643 ARG A 644 0 -6.30 CRYST1 48.643 82.266 59.749 90.00 108.55 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020558 0.000000 0.006899 0.00000 SCALE2 0.000000 0.012156 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017654 0.00000